Date published: 2026-5-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-14 Activators

A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent enzymes that participate in the degradation and remodeling of the extracellular matrix (ECM). ADAMTS-14 is a specific member of this family, sharing its canonical structure that includes a metalloproteinase domain, a disintegrin-like domain, and thrombospondin type 1 repeats. Similar to other family members, ADAMTS-14 is involved in the cleavage of large ECM proteins, including but not limited to aggrecan, versican, and fibronectin. The regulation of ADAMTS-14 activity involves various mechanisms like transcriptional control, post-translational modifications, and interactions with endogenous inhibitors. Factors such as growth factors, cytokines, and oxidative stress can influence the expression and function of ADAMTS-14, thereby shaping the composition and stability of the ECM.

ADAMTS-14 Activators can enhance the activity or expression of ADAMTS-14, either directly or indirectly. Various signaling cascades and regulatory mechanisms can be targeted to achieve this activation. For example, molecules that inhibit pathways known to downregulate ADAMTS-14 expression could serve as indirect activators. Epigenetic modulators, such as histone deacetylase (HDAC) inhibitors, could also facilitate increased gene expression of ADAMTS-14. Another route to activation could involve the stabilization of the ECM by molecules like lysyl oxidase inhibitors, thereby preserving the natural substrates of ADAMTS-14 for cleavage. Small molecules that reduce oxidative stress might also contribute to optimal enzyme function. Collectively, these activators operate through a complex web of biological pathways to modulate ADAMTS-14 activity, ultimately impacting ECM structure and function.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

A TGF-β inhibitor that could upregulate ADAMTS-14 by suppressing signaling pathways that may downregulate its expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

An HDAC inhibitor that could facilitate ADAMTS-14 gene expression by altering the epigenetic landscape.

GM 6001

142880-36-2sc-203979
sc-203979A
1 mg
5 mg
$77.00
$270.00
55
(1)

An MMP inhibitor that could maintain the ECM substrates available for ADAMTS-14 activity, thus potentially indirectly activating it.

3-Aminopropionitrile

151-18-8sc-266473
1 g
$104.00
(0)

These could stabilize the ECM, affecting the substrate availability for ADAMTS-14.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

A PDGF Small Molecule Inhibitor that could influence ADAMTS-14 activity by interfering with growth factor-mediated ECM remodeling.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

An Nrf2 activator that could affect ADAMTS-14, particularly under conditions of oxidative stress.

Dimethyloxaloylglycine (DMOG)

89464-63-1sc-200755
sc-200755A
sc-200755B
sc-200755C
10 mg
50 mg
100 mg
500 mg
$84.00
$301.00
$374.00
$779.00
25
(2)

A hydroxylase inhibitor that might modulate post-translational modifications affecting the stability or activity of ADAMTS-14.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

As a reactive oxygen species (ROS) scavenger, this molecule could potentially activate ADAMTS-14 by reducing oxidative stress that may impair its activity.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

A gamma-secretase inhibitor that interferes with Notch signaling could indirectly affect ADAMTS-14 expression or activity.